CategoryMedical & Pharma
Advances in Inflammatory Bowel Diseases - AIBD
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Advances in Inflammatory Bowel Diseases - AIBD — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Advances in Inflammatory Bowel Diseases - AIBD 2026
Date: December 7–9, 2026 (Workshop Day: December 6, 2026)
Venue: Walt Disney Swan & Dolphin Hotel, Orlando, Florida, USA
Event Overview: Celebrating its 25th Anniversary, Advances in IBD 2026 is a premier inflammatory bowel disease conference designed for gastroenterologists, advanced practice providers, nurses, fellows, surgeons, researchers, and multidisciplinary healthcare professionals. This event offers evidence-based education on Crohn’s disease, ulcerative colitis, emerging therapies, and real-world IBD care strategies.
Key Highlights
- 2500+ attendees from multidisciplinary IBD specialties
- 75+ expert faculty delivering practical, case-based guidance
- 150+ research abstracts and 100+ presentations
- Workshop Day (December 6) focusing on multidisciplinary care, advanced therapies, and leadership development
- Networking opportunities with clinicians facing similar day-to-day challenges
- CME/CE credits available for professional development
Learning Objectives
Attendees will gain actionable insights to implement the latest clinical research, advanced therapies, and treatment updates into everyday practice. Sessions will emphasize:
- Translating clinical data into real-world patient care
- Managing complex cases of Crohn’s disease and ulcerative colitis
- Leveraging biologics and novel treatment strategies
- Improving multidisciplinary collaboration in IBD care
Who Should Attend?
This conference is tailored for:
- Gastroenterologists and hepatologists
- Advanced practice providers (NPs, PAs)
- IBD nurses and care coordinators
- Medical fellows and residents
- Surgeons and researchers specializing in digestive diseases
- Healthcare professionals involved in IBD patient management
Conference Features
- Fellows Travel Grant: Financial support for fellows to attend the conference (applications accepted until specified deadlines).
- Sherman Prize Recognition: Honoring exceptional contributions to the field of IBD.
- Interactive Sessions: Case discussions, hands-on workshops, and peer networking.
- Abstract Submissions: Researchers can submit original work for presentation by September 4, 2026.
Why Attend?
Advances in IBD 2026 provides a unique platform to:
- Engage with leading experts in IBD research and clinical practice
- Access cutting-edge therapies and treatment protocols
- Build collaborative relationships within the IBD community
- Earn continuing education credits while enhancing patient care skills
Registration: Visit www.advancesinibd.com to register or learn more about pricing, hotel accommodations, and program details.
Data sheet
Advances in Inflammatory Bowel Diseases - AIBD – Event Attendee & Buyer Profile Analysis
Event Date: December 7–9, 2026 (Workshop Day: December 6, 2026)
Location: Orlando, Florida, United States
Event Status: Upcoming
Research Date: June 30, 2026
Event Overview
| Field | Details |
|---|---|
| Event Name | Advances in Inflammatory Bowel Diseases - AIBD |
| Event Date | December 7–9, 2026; Workshop Day: December 6, 2026 |
| Event Status | Upcoming |
| Venue | Walt Disney Swan & Dolphin Hotel |
| City | Orlando |
| State / Region | Florida |
| Country | United States |
| Organizer | Not clearly identifiable from the provided official website content; event branding indicates the AIBD conference platform. |
| Official Event Website | advancesinibd.com |
| Event Type | Medical education conference / clinical summit |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Business Services |
| Audience Reach | National with selective international professional reach |
| Estimated Attendance / Expected Footfall | Estimated 2,500+ based on event marketing description; not independently verified |
| Attendance Data Reliability | Estimated. Attendance figure not publicly confirmed by the organizer. |
| Main Purpose of Event | Evidence-based education, clinical best-practice exchange, case-based learning, research presentation, and multidisciplinary networking in inflammatory bowel disease (IBD). |
About the Event
Advances in Inflammatory Bowel Diseases - AIBD is a specialized clinical conference focused on the diagnosis, treatment, and long-term management of Crohn’s disease, ulcerative colitis, and related inflammatory bowel conditions. The meeting is designed for a multidisciplinary audience that includes gastroenterologists, advanced practice providers, nurses, fellows, surgeons, researchers, and other healthcare professionals who participate in IBD care.
The event is important because it functions as a high-value education and networking platform where clinical practice, research findings, and treatment innovation intersect. Its market position is strongest as a specialist medical education event rather than a broad trade show, making it highly relevant for pharmaceutical companies, medical device vendors, diagnostic providers, health systems, academic centers, and service partners seeking to engage IBD decision-makers and care teams.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Gastroenterology clinicians | Hospitals, GI groups, academic medical centers, specialty clinics | Prescribers, protocol influencers, product evaluators | High-value audience for therapies, diagnostics, patient-support, and clinical tools |
| Advanced practice providers | Hospitals, specialty practices, care teams | Care-pathway implementers and end-user influencers | Useful for education, adherence, remote-monitoring, and workflow solutions |
| Nursing leadership and IBD nurses | Hospitals, infusion centers, specialty clinics | Patient education and treatment coordination influence | Strong fit for patient engagement, compliance, and support programs |
| Fellows and residents | Teaching hospitals, universities | Future prescribers and research leaders | Valuable for early brand familiarity and education programs |
| Colorectal and general surgeons | Hospitals, surgical groups, academic centers | Treatment pathway decision-makers | Relevant for surgical devices, imaging, perioperative care, and referral solutions |
| Researchers / clinical investigators | Universities, hospitals, research institutes | Trial design, evidence generation, KOL influence | Important for research partnerships, RWE platforms, and trial recruitment tools |
| Pharma / biotech medical affairs | Biopharma and biotechnology companies | Clinical education, KOL engagement, evidence generation | High fit for therapies, data services, and patient-support services |
| Market access / payer teams | Payers, pharma, health systems | Coverage, access, and adoption strategy | Relevant for real-world evidence, outcomes, and patient access solutions |
| Hospital pharmacy / formulary teams | Hospitals, integrated delivery networks | Formulary and utilization management | Critical for drug access, infusion, and specialty pharmacy engagement |
| Patient advocacy / association leaders | Nonprofits, disease foundations, advocacy groups | Awareness and education multipliers | Useful for community outreach and education partnerships |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Orlando | Central Florida healthcare systems, physician groups, and hotel-accessible attendees | Medium | Strong destination-event accessibility supports broad professional turnout |
| Host state: Florida | Florida hospitals, academic centers, GI practices, and specialty clinics | High | Likely concentration of Southeast U.S. attendees |
| Nearby business hubs | Atlanta, Miami, Tampa, Jacksonville, Charlotte, Raleigh-Durham | Medium | Convenient air access makes multi-state regional participation likely |
| National reach | U.S. academic medical centers, GI practices, pharma teams, researchers | High | Conference topic is specialized but nationally relevant |
| International reach | Selected global KOLs, researchers, and industry specialists | Low to Medium | Likely limited but meaningful international scientific participation |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The subject matter is specialized, but the target audience spans the U.S. clinical, academic, and pharmaceutical ecosystem. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Mayo Clinic | Health system / academic medical center | Large GI and IBD care network; strong clinical education buyer fit | mayoclinic.org | Chief of Gastroenterology, GI Division Director, IBD Specialist, Clinical Research Director | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Health system / academic medical center | Major tertiary GI program and research environment | clevelandclinic.org | Gastroenterology Chair, IBD Center Director, Physician Leader, Medical Affairs | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic medical center | Research-intensive institution with specialty GI decision-makers | hopkinsmedicine.org | GI Faculty, Clinical Research PI, Department Administrator, Fellowship Director | Strong Market Fit, Attendance Not Confirmed |
| University of Pennsylvania Health System | Academic health system | IBD-focused clinical and research buyers | pennmedicine.org | IBD Program Director, GI Chair, Outcomes Research Lead, Specialty Pharmacy Leader | Strong Market Fit, Attendance Not Confirmed |
| Mount Sinai Health System | Academic medical center | High-volume GI and translational research organization | mountsinai.org | IBD Center Lead, Gastroenterologist, Research Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Cedars-Sinai | Academic medical center | Prominent digestive disease and clinical research institution | cedars-sinai.org | Gastroenterology Leadership, Clinical Trials Manager, Department Chair | Strong Market Fit, Attendance Not Confirmed |
| Kaiser Permanente | Integrated health system | Large population health and specialty care buyer; outcomes-focused | kp.org | Medical Director, Pharmacy & Therapeutics, GI Service Line Leader | Strong Market Fit, Attendance Not Confirmed |
| Takeda | Pharmaceutical company | IBD-relevant therapy stakeholder; commercial and medical affairs audience | takeda.com | Medical Science Liaison, Medical Affairs Director, Brand Director, Market Access | Strong Market Fit, Attendance Not Confirmed |
| AbbVie | Pharmaceutical company | Major immunology and GI market participant | abbvie.com | Medical Affairs, MSL, Access, Brand Strategy, HEOR | Strong Market Fit, Attendance Not Confirmed |
| Johnson & Johnson Innovative Medicine | Pharmaceutical company | Relevant immunology and specialty care stakeholder | jnj.com | Medical Director, Field Medical, Clinical Development, Patient Support | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical company | Immunology, medical affairs, and evidence generation stakeholders | pfizer.com | Medical Affairs, HEOR, Clinical Research, Market Access | Strong Market Fit, Attendance Not Confirmed |
| United States Department of Veterans Affairs | Government health system | Large provider network with GI care and clinical training needs | va.gov | Clinical Program Manager, GI Service Lead, Procurement, Research Administrator | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief of Gastroenterology / GI Division Director | Clinical leadership | Executive / Director | Owns therapeutic adoption, faculty participation, and program strategy. |
| 2 | IBD Specialist / Gastroenterologist | Clinical | Senior / Mid | Primary clinical decision-maker and education attendee. |
| 3 | Medical Affairs Director | Medical affairs | Director / VP | Influences KOL engagement, education strategy, and scientific exchange. |
| 4 | Clinical Research Director / PI | Research | Director / Senior | Relevant for evidence generation, trial recruitment, and RWE partnerships. |
| 5 | IBD Nurse Manager / Nurse Educator | Nursing | Manager / Lead | Influences patient support workflows and adherence education. |
| 6 | Advanced Practice Provider (NP/PA) | Clinical | Mid | Key implementer of care protocols and patient education. |
| 7 | Hospital Pharmacy / Formulary Lead | Pharmacy | Manager / Director | Impacts access, utilization, and therapy adoption decisions. |
| 8 | Market Access / HEOR Lead | Payer / commercial | Manager / Director | Needs outcomes evidence, access strategy, and utilization insights. |
| 9 | Clinical Trial Manager | Research operations | Manager | Useful for recruitment, site support, and research technology vendors. |
| 10 | Product Manager / Brand Manager | Commercial | Manager / Director | Aligns product messaging and field education with clinician needs. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core audience of clinicians and health systems | Clinical education, patient support, workflows, procurement |
| 2 | Pharmaceuticals | Therapy manufacturers and medical affairs stakeholders | KOL engagement, clinical programs, access |
| 3 | Biotechnology | Novel therapeutics and research collaboration | Trials, research partnerships, scientific sponsorship |
| 4 | Medical Devices | Endoscopy, monitoring, and clinical tools ecosystem | Device education, clinical adoption, sales outreach |
| 5 | Research | Academic and clinical research presence is central | Research platforms, registries, analytics, CRO support |
| 6 | Information Technology & Services | Digital workflow, data capture, telehealth, and patient engagement | EHR integration, analytics, remote monitoring |
| 7 | Information Services | Clinical evidence, data, and market intelligence demand | HEOR, analytics, patient insights |
| 8 | Management Consulting | Health strategy and transformation projects | Advisory services for providers and life sciences |
| 9 | Market Research | Patient and clinician insight generation | IBD market sizing, patient journey, voice-of-customer |
| 10 | Biotechnology Research | Scientific innovation and translational research | Lab tools, trial support, biomarker services |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 2,500+ | Estimated | Event marketing description supplied by user | Not independently verified from official site content |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor list accessible in provided official website text | Attendance figure not publicly confirmed by the organizer. |
| Buyer count | Not publicly confirmed | Unconfirmed | Derived from expected multidisciplinary attendance | Useful for lead generation, but not a verified count |
| Speaker count | 75+ expert faculty | Estimated / marketing claim | Event description supplied by user | Not independently verified here |
| Abstract / presentation volume | 150+ research abstracts; 100+ presentations | Estimated / marketing claim | Event description supplied by user | Strong indicator of scientific depth |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical education | Updated treatment pathways and case-based guidance | Sponsored sessions, CME support, peer-to-peer education | Medical education services, conference sponsorships |
| Advanced therapies | Biologics, immunology, and treatment sequencing | Medical affairs meetings, field engagement, access discussions | Pharma products, biologics, access tools |
| Research / evidence generation | Clinical outcomes, registries, RWE, trial collaboration | Research networking, abstract review, investigator outreach | CROs, data platforms, analytics, trial services |
| Patient support / adherence | Improve therapy persistence and care coordination | Nurse engagement, app demos, support-program meetings | Patient support services, remote monitoring, adherence tools |
| Care delivery workflow | Operational efficiency in GI clinics and infusion workflows | Practice management and workflow improvement conversations | EHR-integrated tools, scheduling, operations software |
| Market access | Coverage, formulary, and reimbursement support | Payer discussions, formulary evidence, HEOR engagement | Access strategy, HEOR, reimbursement services |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Attendees include clinicians, researchers, pharma, and health-system stakeholders directly tied to IBD care. |
| Decision-maker availability | High | Strong concentration of senior clinicians, medical affairs, and research leaders. |
| Data collection potential | Medium | Useful event for lead generation, though attendee-level public data appears limited. |
| Apollo targeting potential | Very High | Clear industry, title, and department filters exist across healthcare, pharma, and research. |
| Geographic targeting potential | High | Targeting can focus on U.S. health systems, academic centers, and pharma hubs. |
| Best outreach approach | High-touch / account-based | Use clinical relevance, education value, and patient outcome benefits in messaging. |
| Overall lead quality | High | This is a strong specialty event for healthcare and life-sciences prospecting. |
| Best use case | B2B attendee list building and KOL outreach | Best for pharma, medtech, diagnostics, research services, and healthcare technology. |
| Limitations / risks | Medium | Official attendee/exhibitor lists were not accessible in the provided site text; current-year participation cannot be confirmed broadly. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Research; Information Technology & Services; Market Research; Management Consulting | Capture clinical, commercial, and research buyer ecosystems |
| Departments | Clinical, Medical Affairs, Research, Pharmacy, Market Access, Commercial, Operations | Reach buying and influencing teams |
| Seniority | Manager, Director, VP, CXO, Owner, Partner, Head | Prioritize decision-makers and program owners |
| Job titles | Gastroenterologist, IBD Specialist, GI Director, Medical Affairs Director, Medical Science Liaison, Clinical Research Director, Pharmacy Director, HEOR Lead, Clinical Program Manager, Nurse Manager | Most event-relevant functional targets |
| Geography | United States; focus on Florida, Southeast, Northeast, Midwest, California, Texas | Matches attendance and major health-system footprints |
| Employee size | 51-200, 201-500, 501-1,000, 1,001-5,000, 5,001+ | Covers specialty groups, health systems, pharma, and research organizations |
| Keywords | IBD, inflammatory bowel disease, Crohn’s, ulcerative colitis, gastroenterology, biologics, immunology, clinical trials, patient support, real-world evidence | Improves precision for event-relevant accounts |
| Company type | Private, public, nonprofit, academic, health system | Broadens coverage across care, research, and life sciences |
Suggested Apollo Search Logic: (IBD OR inflammatory bowel disease OR Crohn’s OR ulcerative colitis OR gastroenterology) AND (Hospital & Health Care OR Pharmaceuticals OR Biotechnology OR Medical Devices OR Research) AND (Director OR VP OR Head OR Manager OR Chief OR Specialist OR Fellow OR Medical Affairs OR Clinical Research).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Advances in IBD official website | Official event website | Event branding and access to official pages; provided copy did not expose full date/venue content in the captured text | High, but content capture was incomplete |
| Walt Disney Swan & Dolphin Hotel | Venue website | Venue identity and location context | High |
| User-provided event description | Provided event brief | Dates, workshop day, attendee mix, faculty estimate, abstracts, presentations, and attendance marketing claim | Medium; not independently verified here |
| Crohn's & Colitis Foundation | Association / disease foundation | IBD ecosystem context and stakeholder relevance | Medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Advances in Inflammatory Bowel Diseases - AIBD — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds